GlassScriptPhysician profile
Daniel Kp Noonan
NPI 1942474853
$94,815.55
in general payments reported to CMS, 2019-2025
20 companies · $15K in 2025
The $15K reported for 2025 was more than what 86% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $18K · 2021: $1,735 · 2022: $4,762 · 2023: $2,559 · 2024: $28K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Travel and Lodging: $4,723 · Food and Beverage: $4,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,863.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Travel and Lodging | $4,722.92 |
| Food and Beverage | $4,534.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $74,296.14 | 2019-2025 | Amplatzer Amulet, Jeti All In One Non-Sterile Kit, Accent |
| Boston Scientific Corporation | $18,566.22 | 2019-2025 | Watchman Access System, Ingevity Mri, Lux-Dx Insertable Cardiac Monitor |
| Impulse Dynamics (USA) INC. | $513.77 | 2023-2025 | Optimizer, Optimizer |
| Medtronic, INC. | $271.38 | 2023-2025 | Pulseselect, Cobalt Dr Mri Surescan |
| Cleerly, INC. | $152.05 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Novartis Pharmaceuticals Corporation | $151.08 | 2023-2024 | |
| Siemens Medical Solutions USA, INC. | $146.69 | 2023 | Biograph Horizon-3r |
| Pfizer INC. | $140.76 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $138.64 | 2021-2025 | Camzyos, Eliquis |
| Philips North America LLC | $87.52 | 2023 | |
| Biotronik INC. | $78.75 | 2019-2024 | Biomonitor |
| Cardiva Medical, INC. | $59.79 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $44.15 | 2023-2024 | Repatha |
| Novo Nordisk INC | $43.17 | 2023-2024 | Wegovy |
| Abiomed | $30.74 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $24.67 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $19.99 | 2023 | |
| Medtronic Vascular, INC. | $18.63 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $15.79 | 2024 | |
| Recor Medical INC | $15.62 | 2024 | Paradise Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Noonan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.